117 related articles for article (PubMed ID: 2127565)
1. Pharmacological profile of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
Hanna N; Marshall PJ; Newton J; Schwartz L; Kirsh R; Dimartino MJ; Adams J; Bender P; Griswold DE
Drugs Exp Clin Res; 1990; 16(4):137-47. PubMed ID: 2127565
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Marshall PJ; Griswold DE; Breton J; Webb EF; Hillegass LM; Sarau HM; Newton J; Lee JC; Bender PE; Hanna N
Biochem Pharmacol; 1991 Jul; 42(4):813-24. PubMed ID: 1907824
[TBL] [Abstract][Full Text] [Related]
3. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.
Griswold DE; Marshall PJ; Lee JC; Webb EF; Hillegass LM; Wartell J; Newton J; Hanna N
Biochem Pharmacol; 1991 Jul; 42(4):825-31. PubMed ID: 1907825
[TBL] [Abstract][Full Text] [Related]
6. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Griswold DE; Marshall PJ; Webb EF; Godfrey R; Newton J; DiMartino MJ; Sarau HM; Gleason JG; Poste G; Hanna N
Biochem Pharmacol; 1987 Oct; 36(20):3463-70. PubMed ID: 2823821
[TBL] [Abstract][Full Text] [Related]
7. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
8. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
10. Arachidonic acid-induced pleurisy (ARIP): an in vivo model for testing 5-lipoxygenase inhibition.
Boctor AM; Burke C; Hovinga ME
Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):793-7. PubMed ID: 2831442
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamide.
Bailey PJ; Dallob AL; Allison DL; Anderson RL; Bach T; Durette PL; Hand KM; Hopple SL; Luell S; Meurer R
Arzneimittelforschung; 1988 Mar; 38(3):372-8. PubMed ID: 3132928
[TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor.
Li L; Ji H; Sheng L; Zhang Y; Lai Y; Chen X
Eur J Pharmacol; 2009 Apr; 607(1-3):244-50. PubMed ID: 19243697
[TBL] [Abstract][Full Text] [Related]
13. Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses.
Kim SY; Moon TC; Chang HW; Son KH; Kang SS; Kim HP
Phytother Res; 2002 Nov; 16(7):616-20. PubMed ID: 12410540
[TBL] [Abstract][Full Text] [Related]
14. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
Lesch CA; Gilbertsen RB; Song Y; Dyer RD; Schrier D; Kraus ER; Sanchez B; Guglietta A
J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
[TBL] [Abstract][Full Text] [Related]
15. Analgetic activity of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
Griswold DE; Marshall P; Martin L; Webb EF; Zabko-Potapovich B
Agents Actions Suppl; 1991; 32():113-7. PubMed ID: 1906235
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compound.
Wiesenberg-Boettcher I; Schweizer A; Green JR; Mueller K; Maerki F; Pfeilschifter J
Drugs Exp Clin Res; 1989; 15(11-12):501-9. PubMed ID: 2517780
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493.
Griswold DE; Hoffstein S; Marshall PJ; Webb EF; Hillegass L; Bender PE; Hanna N
Inflammation; 1989 Dec; 13(6):727-39. PubMed ID: 2559032
[TBL] [Abstract][Full Text] [Related]
18. Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations.
Coersmeier C; Wittenberg HR; Aehringhaus U; Dreyling KW; Peskar BM; Brune K; Peskar BA
Agents Actions Suppl; 1986; 19():137-54. PubMed ID: 3092600
[TBL] [Abstract][Full Text] [Related]
19. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs.
Curnock AP; Robson PA; Yea CM; Moss D; Gadher S; Thomson TA; Westwood R; Ruuth E; Williamson RA
J Pharmacol Exp Ther; 1997 Jul; 282(1):339-47. PubMed ID: 9223572
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of eicosanoids in the pharmacological action of bromelain.
Vellini M; Desideri D; Milanese A; Omini C; Daffonchio L; Hernandez A; Brunelli G
Arzneimittelforschung; 1986; 36(1):110-2. PubMed ID: 3006709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]